Verified Supplement Data Primary-sourced

Zen Principle Naturals Moringa Leaf Powder recall (August 2026): reason, lots, what to do

By Erin Rose · Published · FDA record as of · All supplement recalls

Not medical advice. This page reproduces one FDA enforcement report and explains its fields; FDA’s text is quoted as FDA’s. If you have this product and any symptoms, your pharmacist or doctor comes before this page.

What was recalled

FACTORY6, INC. (Lindon, UT) recalled Zen Principle Naturals Moringa Leaf Powder in a recall FDA classified as Class I. FDA’s stated reason: “Possible Salmonella in Moringa Leaf Powder product.”. Started July 19, 2026; posted in the enforcement report August 12, 2026; status Ongoing.

Class I means, in FDA’s words, a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. Distribution: “Distributed to Nevada for further distribution.”. Quantity: 2,048 bottles. Check your lot →

FDA classIContamination (microbial, heavy metal, foreign matter)
Products in the event1one product record
Start to report24 days2026-07-19 → 2026-08-12

The FDA record

Everything in this table is copied from FDA’s enforcement report for event 99425, retrieved from openFDA on September 21, 2026; the last row links to the live record so you can confirm it has not changed.

Recalling firmFACTORY6, INC., Lindon, UT
Product

Zen Principle Naturals Moringa Leaf Powder dietary supplement, 900mg capsules, 180 capsules per PET white bottle. Intended Use: take 2 capsules per day. Route of Administration: OraI. Manufactured for Zen Principle 774 Mays Blvd Incline Village, NV 89451. The product is offered as a 1-pack (180 capsules; Amazon code/FNSKU X000ZJJ4FT) and as a 2-pack (twin pack, 360 capsules; Amazon code/FNSKU X00159YJXP).

Reason for recall (FDA’s text)

“Possible Salmonella in Moringa Leaf Powder product.”

ClassificationClass I
StatusOngoing
Recall typeVoluntary: Firm initiated
Recall initiated2026-07-19
Enforcement report date2026-08-12
FDA classified on2026-08-05
DistributionDistributed to Nevada for further distribution.
Quantity2,048 bottles
How the firm notifiedPress Release
Recall numberH-1222-2026

Lots, codes and how to check your bottle

FDA’s “code info” field for this event, verbatim:

  • LOT: A6FF4, Best By: 11/2028

Find the lot number on the bottom of the container, beside the seal or on the box flap; the expiration date is usually printed next to it. If the code on your container appears above, it is in scope. If the product name matches but the code does not, your unit is not part of this recall, though a second lot is sometimes added later, so re-check the recall list before finishing the bottle.

Why this is a Class I recall

FDA assigns the class by the probability and severity of harm, not by how much product is involved. For this event the reason falls into what we file as contamination (microbial, heavy metal, foreign matter): the product, or a raw material in it, may carry a pathogen, a foreign material or a chemical contaminant. The product itself may be exactly what the label says; the problem is what came with it.

FDA’s definition of Class I (21 CFR 7.3) is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. A Class I recall is the strongest signal FDA sends about a consumer product short of a seizure; it is reserved for the cases where continuing to use the product is itself the risk. The reason text is the authority for this specific event; the class is FDA’s summary judgement of it.

If you bought it

  1. Stop taking it now; for a Class I recall this is the point of the notice.
  2. Match your lot against the codes above. Keep the container: the firm’s notice normally offers a refund on proof of the lot number or a photo.
  3. If you have had symptoms consistent with the contaminant FDA names, tell your doctor and mention the product by name. Then report to FDA MedWatch (online form or 1-800-FDA-1088).
  4. Check the firm’s other products. A recall event often expands to the same firm’s other SKUs a week or two later. Search “FACTORY6, INC.” on the full recall list.

Choosing a replacement that can be checked

This product does not name an ingredient we track, so there is no like-for-like guide to send you to. The general rule holds: the only supplements whose contents a buyer can verify are those in a certifier’s public registry (NSF/ANSI 173, NSF Certified for Sport, USP Verified, Informed Sport) or with a lot-specific certificate of analysis the brand publishes. Our registry audit shows how few products clear that bar, and the per-ingredient third-party-tested pages (magnesium, creatine, vitamin D, omega-3, multivitamins) list the ones that do.

Frequently asked questions

Why was Zen Principle Naturals Moringa Leaf Powder recalled?

FDA's enforcement report gives the reason as: "Possible Salmonella in Moringa Leaf Powder product.". FDA records the recall type as "Voluntary: Firm initiated"; FACTORY6, INC. of Lindon, UT started it July 19, 2026 and it was posted in FDA's enforcement report on August 12, 2026 as Class I.

Which lots of Zen Principle Naturals Moringa Leaf Powder are affected?

FDA's record lists: LOT: A6FF4, Best By: 11/2028. Match these against the lot number, UPC or expiration date printed on your container; a bottle whose code is not listed is not part of this recall.

Where was Zen Principle Naturals Moringa Leaf Powder sold?

FDA's record gives the distribution as: "Distributed to Nevada for further distribution.". Quantity recalled: 2,048 bottles.

Is this recall over?

FDA lists the status as "Ongoing". Ongoing means the firm is still retrieving product from the market.

← Every FDA dietary supplement recall since 2023 · How we score supplement safety

Sources

  1. U.S. Food and Drug Administration. Enforcement report, event 99425, recall number H-1222-2026. Via openFDA Food Enforcement API, retrieved September 21, 2026. H-1222-2026
  2. 21 CFR 7.3(m): recall classification definitions. eCFR Title 21 Part 7.
  3. FDA. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. fda.gov/safety/medwatch.